Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):943–949. doi: 10.1128/aac.41.5.943

Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

M T Nüesch-Inderbinen 1, F H Kayser 1, H Hächler 1
PMCID: PMC163830  PMID: 9145849

Abstract

Sixty isolates of Enterobacteriaceae resistant to beta-lactam antibiotics were collected over a period of 2 years in Switzerland and screened by hybridization for the carriage of SHV genes. Thirty-four positive strains were found, and their SHV genes were amplified and sequenced. SHV extended-spectrum beta-lactamases (ESBLs) were found: 13 strains contained SHV-2a, 12 harbored SHV-2, and SHV-5 was found twice. Four strains were shown to contain SHV-1. In addition, we report two new SHV variants, termed SHV-11 (non-ESBL) and SHV-12 (ESBL). In spite of the carriage of SHV ESBLs, many strains showed only low resistance to one or more third-generation cephalosporins. In addition, 26 did not transfer the blaSHV gene in mating experiments.

Full Text

The Full Text of this article is available as a PDF (911.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambler R. P., Coulson A. F., Frère J. M., Ghuysen J. M., Joris B., Forsman M., Levesque R. C., Tiraby G., Waley S. G. A standard numbering scheme for the class A beta-lactamases. Biochem J. 1991 May 15;276(Pt 1):269–270. doi: 10.1042/bj2760269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arakawa Y., Ohta M., Kido N., Fujii Y., Komatsu T., Kato N. Close evolutionary relationship between the chromosomally encoded beta-lactamase gene of Klebsiella pneumoniae and the TEM beta-lactamase gene mediated by R plasmids. FEBS Lett. 1986 Oct 20;207(1):69–74. doi: 10.1016/0014-5793(86)80014-x. [DOI] [PubMed] [Google Scholar]
  3. Archambaud M., Gerbaud G., Labau E., Marty N., Courvalin P. Possible in-vivo transfer of beta-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. J Antimicrob Chemother. 1991 Apr;27(4):427–436. doi: 10.1093/jac/27.4.427. [DOI] [PubMed] [Google Scholar]
  4. Barguellil F., Burucoa C., Amor A., Fauchère J. L., Fendri C. In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy. Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):703–706. doi: 10.1007/BF01690879. [DOI] [PubMed] [Google Scholar]
  5. Barthélémy M., Peduzzi J., Labia R. Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1). Biochem J. 1988 Apr 1;251(1):73–79. doi: 10.1042/bj2510073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bauernfeind A., Rosenthal E., Eberlein E., Holley M., Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection. 1993 Jan-Feb;21(1):18–22. doi: 10.1007/BF01739303. [DOI] [PubMed] [Google Scholar]
  7. Ben Hassen A., Bejaoui M., Lakhoua M. R., Ben Redjeb S. Profil épidémiologique de la résistance de 153 souches de Salmonella (S. typhi exclues) isolées en milieu pédiatrique tunisien de 1985 à 1990. Pathol Biol (Paris) 1993 Oct;41(8):706–712. [PubMed] [Google Scholar]
  8. Bouabdallah F., Ben Hassen A., Gargouri A., Boudabbous A., Ben Redjeb S. Plasmides conjugatifs et non conjugatifs chez Salmonella serovar Wien codant pour une beta-lactamase a spectre élargi. Pathol Biol (Paris) 1996 Oct;44(8):701–704. [PubMed] [Google Scholar]
  9. Bradford P. A., Urban C., Jaiswal A., Mariano N., Rasmussen B. A., Projan S. J., Rahal J. J., Bush K. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother. 1995 Apr;39(4):899–905. doi: 10.1128/aac.39.4.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brosius J., Ullrich A., Raker M. A., Gray A., Dull T. J., Gutell R. R., Noller H. F. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid. 1981 Jul;6(1):112–118. doi: 10.1016/0147-619x(81)90058-5. [DOI] [PubMed] [Google Scholar]
  11. Bush K. Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis. 1996 May;15(5):361–364. doi: 10.1007/BF01690090. [DOI] [PubMed] [Google Scholar]
  12. Bush K., Jacoby G. A., Medeiros A. A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995 Jun;39(6):1211–1233. doi: 10.1128/aac.39.6.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cheng Y., Chen M. Extended-spectrum beta-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia coli in China. Antimicrob Agents Chemother. 1994 Dec;38(12):2838–2842. doi: 10.1128/aac.38.12.2838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. French G. L., Shannon K. P., Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. J Clin Microbiol. 1996 Feb;34(2):358–363. doi: 10.1128/jcm.34.2.358-363.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garbarg-Chenon A., Godard V., Labia R., Nicolas J. C. Nucleotide sequence of SHV-2 beta-lactamase gene. Antimicrob Agents Chemother. 1990 Jul;34(7):1444–1446. doi: 10.1128/aac.34.7.1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Garbarg-Chenon A., Vu Thien H., Labia R., Ben-Yaghlane H., Godard V., Deny P., Bricout F., Nicolas J. C. Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium. Drugs Exp Clin Res. 1989;15(4):145–150. [PubMed] [Google Scholar]
  17. Gianneli D., Tzelepi E., Tzouvelekis L. S., Mentis A. F., Nikolopoulou C. Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals. Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):764–767. doi: 10.1007/BF02276063. [DOI] [PubMed] [Google Scholar]
  18. Gutmann L., Ferré B., Goldstein F. W., Rizk N., Pinto-Schuster E., Acar J. F., Collatz E. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother. 1989 Jun;33(6):951–956. doi: 10.1128/aac.33.6.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gutmann L., Kitzis M. D., Billot-Klein D., Goldstein F., Tran Van Nhieu G., Lu T., Carlet J., Collatz E., Williamson R. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Dis. 1988 Jul-Aug;10(4):860–866. doi: 10.1093/clinids/10.4.860. [DOI] [PubMed] [Google Scholar]
  20. Hammami A., Arlet G., Ben Redjeb S., Grimont F., Ben Hassen A., Rekik A., Philippon A. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):641–646. doi: 10.1007/BF01975816. [DOI] [PubMed] [Google Scholar]
  21. Issack M. I., Shannon K. P., Qureshi S. A., French G. L. Extended-spectrum beta-lactamase in Salmonella spp. J Hosp Infect. 1995 Aug;30(4):319–321. doi: 10.1016/0195-6701(95)90269-4. [DOI] [PubMed] [Google Scholar]
  22. Jacoby G. A. Genetics of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 1994;13 (Suppl 1):S2–11. doi: 10.1007/BF02390679. [DOI] [PubMed] [Google Scholar]
  23. Jacoby G. A., Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 1996 Apr;34(4):908–911. doi: 10.1128/jcm.34.4.908-911.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jacoby G. A., Medeiros A. A. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Sep;35(9):1697–1704. doi: 10.1128/aac.35.9.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Karas J. A., Pillay D. G., Muckart D., Sturm A. W. Treatment failure due to extended spectrum beta-lactamase. J Antimicrob Chemother. 1996 Jan;37(1):203–204. doi: 10.1093/jac/37.1.203. [DOI] [PubMed] [Google Scholar]
  26. Katsanis G. P., Spargo J., Ferraro M. J., Sutton L., Jacoby G. A. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol. 1994 Mar;32(3):691–696. doi: 10.1128/jcm.32.3.691-696.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kayser F. H., Morenzoni G., Homberger F. Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests. Antimicrob Agents Chemother. 1982 Jul;22(1):15–22. doi: 10.1128/aac.22.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kliebe C., Nies B. A., Meyer J. F., Tolxdorff-Neutzling R. M., Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1985 Aug;28(2):302–307. doi: 10.1128/aac.28.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lemozy J., Sirot D., Chanal C., Huc C., Labia R., Dabernat H., Sirot J. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains. Antimicrob Agents Chemother. 1995 Nov;39(11):2580–2582. doi: 10.1128/aac.39.11.2580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Livermore D. M. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995 Oct;8(4):557–584. doi: 10.1128/cmr.8.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Marchese A., Arlet G., Schito G. C., Lagrange P. H., Philippon A. Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):245–248. doi: 10.1007/BF01591363. [DOI] [PubMed] [Google Scholar]
  32. Martínez-Martínez L., Hernández-Allés S., Albertí S., Tomás J. M., Benedi V. J., Jacoby G. A. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother. 1996 Feb;40(2):342–348. doi: 10.1128/aac.40.2.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mercier J., Levesque R. C. Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother. 1990 Aug;34(8):1577–1583. doi: 10.1128/aac.34.8.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Morosini M. I., Canton R., Martinez-Beltran J., Negri M. C., Perez-Diaz J. C., Baquero F., Blazquez J. New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother. 1995 Feb;39(2):458–461. doi: 10.1128/aac.39.2.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mulgrave L., Attwood P. V. Characterization of an SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia. Pathology. 1993 Jan;25(1):71–75. doi: 10.3109/00313029309068906. [DOI] [PubMed] [Google Scholar]
  36. Nicolas M. H., Jarlier V., Honore N., Philippon A., Cole S. T. Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1989 Dec;33(12):2096–2100. doi: 10.1128/aac.33.12.2096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nüesch-Inderbinen M. T., Hächler H., Kayser F. H. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996 May;15(5):398–402. doi: 10.1007/BF01690097. [DOI] [PubMed] [Google Scholar]
  38. Nüesch-Inderbinen M. T., Hächler H., Kayser F. H. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases. Antimicrob Agents Chemother. 1995 Aug;39(8):1726–1730. doi: 10.1128/aac.39.8.1726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Philippon A., Labia R., Jacoby G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1989 Aug;33(8):1131–1136. doi: 10.1128/aac.33.8.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Podbielski A., Melzer B. Nucleotide sequence of the gene encoding the SHV-2 beta-lactamase (blaSHV-2) of Klebsiella ozaenae. Nucleic Acids Res. 1990 Aug 25;18(16):4916–4916. doi: 10.1093/nar/18.16.4916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Podbielski A., Schönling J., Melzer B., Warnatz K., Leusch H. G. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J Gen Microbiol. 1991 Mar;137(3):569–578. doi: 10.1099/00221287-137-3-569. [DOI] [PubMed] [Google Scholar]
  42. Prinarakis E. E., Tzelepi E., Gazouli M., Mentis A. F., Tzouvelekis L. S. Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol Lett. 1996 Jun 1;139(2-3):229–234. doi: 10.1111/j.1574-6968.1996.tb08207.x. [DOI] [PubMed] [Google Scholar]
  43. Prodinger W. M., Fille M., Bauernfeind A., Stemplinger I., Amann S., Pfausler B., Lass-Florl C., Dierich M. P. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol. 1996 Mar;34(3):564–568. doi: 10.1128/jcm.34.3.564-568.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rahal K., Reghal A. Epidémie nosocomiale à Salmonella mbandaka productrices de différentes beta-lactamases dont une à large spectre: Résultats préliminaires. Med Trop (Mars) 1994;54(3):227–230. [PubMed] [Google Scholar]
  45. Raquet X., Vanhove M., Lamotte-Brasseur J., Goussard S., Courvalin P., Frère J. M. Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins. Proteins. 1995 Sep;23(1):63–72. doi: 10.1002/prot.340230108. [DOI] [PubMed] [Google Scholar]
  46. Rice L. B., Carias L. L., Bonomo R. A., Shlaes D. M. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy. J Infect Dis. 1996 Jan;173(1):151–158. doi: 10.1093/infdis/173.1.151. [DOI] [PubMed] [Google Scholar]
  47. Sasaki Y., Taketomo N., Sasaki T. Factors affecting transfer frequency of pAM beta 1 from Streptococcus faecalis to Lactobacillus plantarum. J Bacteriol. 1988 Dec;170(12):5939–5942. doi: 10.1128/jb.170.12.5939-5942.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schultz S. C., Dalbadie-McFarland G., Neitzel J. J., Richards J. H. Stability of wild-type and mutant RTEM-1 beta-lactamases: effect of the disulfide bond. Proteins. 1987;2(4):290–297. doi: 10.1002/prot.340020405. [DOI] [PubMed] [Google Scholar]
  49. Sirot D. Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother. 1995 Jul;36 (Suppl A):19–34. doi: 10.1093/jac/36.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  50. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  51. Vahaboglu H., Hall L. M., Mulazimoglu L., Dodanli S., Yildirim I., Livermore D. M. Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey. J Med Microbiol. 1995 Oct;43(4):294–299. doi: 10.1099/00222615-43-4-294. [DOI] [PubMed] [Google Scholar]
  52. Vatopoulos A. C., Philippon A., Tzouvelekis L. S., Komninou Z., Legakis N. J. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother. 1990 Nov;26(5):635–648. doi: 10.1093/jac/26.5.635. [DOI] [PubMed] [Google Scholar]
  53. Venezia R. A., Scarano F. J., Preston K. E., Steele L. M., Root T. P., Limberger R., Archinal W., Kacica M. A. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis. 1995 Oct;21(4):915–923. doi: 10.1093/clinids/21.4.915. [DOI] [PubMed] [Google Scholar]
  54. de Champs C., Sirot D., Chanal C., Poupart M. C., Dumas M. P., Sirot J. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother. 1991 Apr;27(4):441–457. doi: 10.1093/jac/27.4.441. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES